19092-Solid Tumors-NA-497

Solid Tumors

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number:

  • Address

1200 Brooklyn Ave, Suite 115
San Antonio, TX 78212
P: (210) 224-6531

Search by practice name, trial titles, indicators and specific disease types.